262 related articles for article (PubMed ID: 33733975)
21. Hypersensitivity and adverse reactions to biologics for asthma and allergic diseases.
Jackson K; Bahna SL
Expert Rev Clin Immunol; 2020 Mar; 16(3):311-319. PubMed ID: 31994421
[No Abstract] [Full Text] [Related]
22. Biologics and Novel Therapies for Food Allergy.
Albuhairi S; Rachid R
Immunol Allergy Clin North Am; 2021 May; 41(2):271-283. PubMed ID: 33863483
[TBL] [Abstract][Full Text] [Related]
23. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
Katsaounou P; Buhl R; Brusselle G; Pfister P; Martínez R; Wahn U; Bousquet J
Respir Med; 2019 Apr; 150():51-62. PubMed ID: 30961951
[TBL] [Abstract][Full Text] [Related]
24. Biologic Therapies for Immunoglobulin E-mediated Food Allergy and Eosinophilic Esophagitis.
Otani IM; Nadeau KC
Immunol Allergy Clin North Am; 2017 May; 37(2):369-396. PubMed ID: 28366483
[TBL] [Abstract][Full Text] [Related]
25. Effects of omalizumab in patients with food allergy.
Rafi A; Do LT; Katz R; Sheinkopf LE; Simons CW; Klaustermeyer W
Allergy Asthma Proc; 2010; 31(1):76-83. PubMed ID: 20167148
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal Antibodies in Treating Food Allergy: A New Therapeutic Horizon.
Manti S; Pecora G; Patanè F; Giallongo A; Parisi GF; Papale M; Licari A; Marseglia GL; Leonardi S
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371821
[TBL] [Abstract][Full Text] [Related]
27. Determinants of omalizumab dose-related efficacy in oral immunotherapy: Evidence from a cohort of 181 patients.
Azzano P; Paquin M; Langlois A; Morin C; Parizeault G; Lacombe-Barrios J; Samaan K; Graham F; Paradis L; Des Roches A; Bégin P
J Allergy Clin Immunol; 2021 Jan; 147(1):233-243. PubMed ID: 32980425
[TBL] [Abstract][Full Text] [Related]
28. Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.
Scurlock AM
Clin Rev Allergy Immunol; 2018 Oct; 55(2):139-152. PubMed ID: 29656306
[TBL] [Abstract][Full Text] [Related]
29. Omalizumab in children with severe allergic disease: a case series.
Crisafulli G; Caminiti L; Chiera F; Arasi S; Salzano G; Panasiti I; Barbalace A; Pajno GB
Ital J Pediatr; 2019 Jan; 45(1):13. PubMed ID: 30642367
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic Antibodies for Nasal Polyposis Treatment: Where Are We Headed?
Agarwal A; Spath D; Sherris DA; Kita H; Ponikau JU
Clin Rev Allergy Immunol; 2020 Oct; 59(2):141-149. PubMed ID: 31073812
[TBL] [Abstract][Full Text] [Related]
31. Anti-IgE--emerging opportunities for Omalizumab.
Babu KS; Polosa R; Morjaria JB
Expert Opin Biol Ther; 2013 May; 13(5):765-77. PubMed ID: 23517576
[TBL] [Abstract][Full Text] [Related]
32. Omalizumab : other indications and unanswered questions.
Mankad VS; Burks AW
Clin Rev Allergy Immunol; 2005 Aug; 29(1):17-30. PubMed ID: 16222081
[TBL] [Abstract][Full Text] [Related]
33. Nonallergen-specific treatments for food allergy.
Lieberman JA; Wang J
Curr Opin Allergy Clin Immunol; 2012 Jun; 12(3):293-301. PubMed ID: 22475999
[TBL] [Abstract][Full Text] [Related]
34. Use of biologics in allergen immunotherapy.
Pfützner W; Schuppe M
Allergol Select; 2021; 5():108-118. PubMed ID: 33634221
[TBL] [Abstract][Full Text] [Related]
35. Biologics in severe asthma.
Pelaia C; Pelaia G; Crimi C; Longhini F; Lombardo N; Savino R; Sciacqua A; Vatrella A
Minerva Med; 2022 Feb; 113(1):51-62. PubMed ID: 33555158
[TBL] [Abstract][Full Text] [Related]
36. Omalizumab and other biologics in drug desensitization.
Fernandez J; Ruano-Zaragoza M; Blanca-Lopez N
Curr Opin Allergy Clin Immunol; 2020 Aug; 20(4):333-337. PubMed ID: 32398420
[TBL] [Abstract][Full Text] [Related]
37. Omalizumab as monotherapy for food allergy.
Arasi S; Mennini M; Cafarotti A; Fiocchi A
Curr Opin Allergy Clin Immunol; 2021 Jun; 21(3):286-291. PubMed ID: 33769312
[TBL] [Abstract][Full Text] [Related]
38. Novel Therapies for Treatment of Food Allergy.
Albuhairi S; Rachid R
Immunol Allergy Clin North Am; 2020 Feb; 40(1):175-186. PubMed ID: 31761117
[TBL] [Abstract][Full Text] [Related]
39. Biologics and Allergy Immunotherapy in the Treatment of Allergic Diseases.
Cox L
Immunol Allergy Clin North Am; 2020 Nov; 40(4):687-700. PubMed ID: 33012328
[TBL] [Abstract][Full Text] [Related]
40. Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis.
Wu Q; Zhang Y; Kong W; Wang X; Yuan L; Zheng R; Qiu H; Huang X; Yang Q
Int Arch Allergy Immunol; 2022; 183(3):279-288. PubMed ID: 34607329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
